BIOSIG TECHNOLOG. DL-,001 Logo
US09073N2018
A2N5TW
BSGM

BIOSIG TECHNOLOG. DL-,001

Prévisions

L'objectif de cours moyen des analystes est de 0,37 € (-92,24 %). La médiane est de 0,37 € (-92,24 %).

Acheter
  2
Conserver
  0
Vendre
  0

Discussions dans la communauté

Il n'y a pas encore de discussion sur cet actif.

Lancer une discussion

  • BioSig Technologies renamed Streamex Corp after merger and gets new ticker symbol STEX

    BioSig Technologies will change its name to Streamex Corp. effective September 12, 2025, following its merger with Streamex Exchange Corporation, and will change its Nasdaq ticker from BSGM to STEX; shareholders do not need to take any action and the CUSIP remains unchanged. The company completed a committed capital raise of about $15 million by selling 3,852,149 common shares at $3.90 per share and intends to use the net proceeds, among other things, to purchase gold bars and for working capital. Authorized common shares were increased from 200 million to 500 million, and through its subsidiary Streamex the company entered a three‑year exclusive partnership with Monetary Metals to tokenize yield‑bearing gold products. Apart from the rebranding, the structure and operating business are to remain unchanged. » Plus sur de.investing.com


  • Streamex teams up with Monetary Metals for tokenized gold product with up to 4% yield

    Streamex, a subsidiary of BioSig, obtained exclusive three-year rights to tokenize interest-bearing gold products from Monetary Metals and access to its leasing and bond programs. Investors could therefore earn annual returns of up to 4% on tokenized gold bar products; Streamex will finance at least 10% of the qualifying gold-leasing contracts and receive a revenue-linked share. BioSig also raised about USD 15 million through a public offering, will purchase gold bars and is using the capital increase, while InvestingPro points to weak financial metrics and short-term liquidity shortages. » Plus sur de.investing.com


  • BioSig Technologies: shareholders approve share increase and new board structure

    Shareholders of BioSig Technologies voted to increase the authorized common shares from 200 million to 500 million and approved an increase to the long-term incentive plan. They also approved measures to issue common shares and convertible debt in connection with Yorkville and the classification of the board of directors into three classes with staggered three-year terms. The vote on the issuance of about 109,070,079 common shares and one super-voting preferred share related to the Streamex acquisition was deferred pending Nasdaq approval; the meeting will resume on September 26. In addition, BioSig completed an underwritten offering of roughly $15 million and restructured convertible notes with YA II PN, Ltd. (two secured convertible notes of $25 million each, with the option to expand to $50 million). » Plus sur de.investing.com


  • Solana gains major boost as BioSig Technologies tokenizes $1.1 billion in gold on its blockchain

    BioSig Technologies will tokenize up to $1.1 billion in physical gold bullion on the Solana blockchain, significantly increasing Solana's real-world asset footprint. This move highlights Solana's technical strengths, such as low fees and high transaction speeds, and positions it as a leader in the growing asset tokenization trend. The development is seen as a strong validation of Solana's capabilities and a potential catalyst for further growth. » Plus sur finance.yahoo.com


  • BioSig Technologies expands Streamex advisory team with Russell Starr and secures growth financing

    BioSig Technologies has appointed Russell Starr as a strategic advisor for its subsidiary Streamex Exchange Corporation to advance the tokenization of gold reserves and infrastructure. The company also secured up to $1.1 billion in growth financing to support its gold-backed treasury strategy and expanded its advisory team with additional industry experts. Analysts view the stock positively due to the new strategy and potential market returns, despite the company's continued weak financial position. » Plus sur de.investing.com

Données financières

Au dernier trimestre, BIOSIG TECHNOLOG. DL-,001 a réalisé un chiffre d'affaires de 0 € et un bénéfice net de -13,28 M €

(EUR) septembre 2025
YoY
Chiffre d'affaires 0 -
Bénéfice brut 0 -
Bénéfice net -13,28 M -
EBITDA -12,66 M -

Données fondamentales

Indicateur Valeur
Capitalisation boursière
174,19 M €
Nombre d'actions
31,33 M
Plus haut/bas sur 52 semaines
12,86 € - 0,21 €
Dividendes Non
Bêta
1,82
Ratio P/E
-0,03
Ratio PEG
0,00
Ratio P/B
0,42
Ratio P/S
121,85

Profil de l'entreprise

BioSig Technologies, Inc., ainsi que ses filiales, exerce une activité d'entreprise de dispositifs médicaux. Le produit propriétaire de la société comprend le système PURE EP (precise uninterrupted real-time evaluation of electrograms electrophysiology), une plateforme de traitement du signal qui combine matériel et logiciel afin de répondre aux difficultés connues liées à l'acquisition du signal et qui permet aux électrophysiologistes de visualiser les signaux et de les analyser en temps réel. Elle se concentre également sur l'amélioration de l'acquisition du signal intracardiaque et des informations diagnostiques pour les procédures de fibrillation auriculaire, et est conçue pour remédier aux limitations de longue date qui ralentissent et perturbent les procédures d'ablation cardiaque par cathéter. La société a conclu un accord de recherche avec l'Université du Minnesota en vue de mettre au point de nouvelles thérapies destinées à traiter les maladies du système nerveux sympathique, ainsi qu'une collaboration stratégique avec la Mayo Foundation for Medical Education and Research afin de développer une solution logicielle d'IA et d'apprentissage automatique pour les systèmes PURE EP. BioSig Technologies, Inc. a été constituée en 2009 et son siège social se trouve à Westport, Connecticut.

Nom
BIOSIG TECHNOLOG. DL-,001
PDG
Anthony Amato
Siège social Los Angeles, ct
États-Unis
Site web
Secteur
Santé
Industrie
Équipements et fournitures médicaux
Introduction en bourse
31/10/2014
Employés 5

Symboles boursiers

Bourse Symbole
NASDAQ
BSGM
🍪

Parqet  utilise des cookies. En savoir plus